Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLAXO (GLX) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (169)	3/4/1998 8:43:00 AM
From: Zoltan!	Read Replies (1) \| Respond to of 222

Glaxo Wellcome Commercial Paper Rated Prime-1 By Moody's - Dow Jones Newswires -- March 3, 1998 NEW YORK (Dow Jones)--Moody's Investors Service assigned a Prime-1 rating for commercial paper to Glaxo Wellcome Inc., a U.S. subsidiary of Glaxo Wellcome PLC. Moody's said: "The rating is based on the full and unconditional guarantee of the parent, Glaxo Wellcome PLC, whose existing commercial paper rating is Prime-1 and whose senior long-term debt is rated Aa3. "Moody's ratings for Glaxo Wellcome PLC are supported by the company's position as one of the world's top research-based pharmaceutical companies, a strong financial profile, and the prospect that operating performance will strengthen later this year......" interactive2.wsj.com